OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← FXG management

Full background report

Joseph Webb

Executive Director

Career chronology

Contributions and company outcomes

U.S. antimony platform advanced to permitted bulk sampling and pilot production

2026 · issuer reported · medium materiality

Issuer site at cutoff reports bulk sample permit, first ore positioned in the United States and pilot plant antimony metal by 27 August 2026; role overlap only, individual contribution not separately documented.

Attribution: Role overlaps event; causation unproven. The source establishes the executive’s role during or around the event; individual causation is not inferred unless the cited record directly says so.

Relevance: Adds role-specific career, delivery or governance context; distinguish company-level outcomes from individual responsibility.

Directors and management (Issuer site at cutoff reports bulk sample permit, first ore positioned in the United States and pilot plant antimony metal by 27 August 2026; role overlap only, individual contribution not separately documented.)

Suitability for the current role

Limited public evidence for role fit

since 2023 · analyst inference · low materiality

The issuer identifies Joseph Webb as Executive Director. The cited source establishes the disclosed role and any stated appointment date. This source alone does not establish attributable prior-employer outcomes, verified credentials or independently benchmarked delivery. This is an evidence limitation, not an adverse personal finding.

Attribution: Responsibility not applicable. No personal outcome responsibility is inferred from the title alone.

Relevance: The role is relevant to the company’s current leadership assessment; fuller role-fit comparison requires verified chronology and outcome evidence.

Annual Report to shareholders (Corporate directory, key management personnel or appointment disclosure; role and date)

Evidence gaps

  • Prior-employer chronology and qualifications are based mainly on issuer disclosures; independent employment and credential verification was not available in the reviewed public record.

  • The documented name/employer searches are not an exhaustive court, ASIC, sanctions, safety or environmental registry check; no relevant adverse finding surfaced in the searches documented.

  • Company-level outcomes are not attributed personally without a source connecting the executive to the action or result.